Head-to-head · WeighScore
Strut Health vs ShedRx
The verdict
ShedRx takes it — 87/100 to 82/100.
ShedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The widest formulation spread on the board — injection, drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.
We may earn a commission if you start care through some of these links, at no extra cost to you. Affiliate partners are listed first — a capped 3-point edge in board order only. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Strut Health | ShedRx |
|---|---|---|
| WeighScore | 82/100 | 87/100 |
| Grade | B− | B+ |
| Scorecard rank | #20 | #4 |
| Semaglutide | From $99/mo sublingual, $149/mo injectable | $199/mo |
| Tirzepatide | From $199/mo either route | $299/mo |
| Coverage | 49 states (not Arkansas) | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Yes | Yes |
Graded #20 · B−
Strengths
- Sublingual lozenges for both molecules at the same price as the injection — semaglutide from $99/mo, tirzepatide from $199/mo
- Every route and auto-refill saving published on the product page rather than inside an intake
- Free physician visit, free shipping and free follow-up care included
- Cancel, pause or delay yourself with 48 hours' notice
Where it loses points
- Asynchronous by design — some states need no phone consultation, so you may never speak to the prescriber
- No published lab or monitoring programme
- Compounded only, with no brand-name lane
- Not available in Arkansas
Graded #4 · B+
Strengths
- Four GLP-1 routes — injection, liquid drops, lozenges and an oral daily pill
- Brand Zepbound and Wegovy available beside the compounded line
- Health coaching included with membership, plus a published 120-day weight-loss guarantee
Where it loses points
- The advertised "as low as $239" tirzepatide rate requires a twelve-month commitment — month-to-month is $299
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
- The dispensing compounding pharmacy is not publicly named
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 43 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.